News
Feed
Events
Feed
News
+ Events
Feed

BB BIOTECH AG

  • ISIN CH0038389992
  • Country Switzerland

Latest News

26 March 2024

17:40 Directors’ Dealings

BB BIOTECH AG

Directors’ Dealings

BB BIOTECH AG: Dr. Thomas von Planta, buy

17:40 Directors’ Dealings

BB BIOTECH AG

Directors’ Dealings

BB BIOTECH AG: Dr. Thomas von Planta, buy

21 March 2024

18:00 Corporate

BB BIOTECH AG

Corporate

Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.00 per share

21 February 2024

17:40 Directors’ Dealings

BB BIOTECH AG

Directors’ Dealings

BB BIOTECH AG: Prof. Dr. Mads Krogsgaard Thomsen, buy

16 February 2024

07:00 Ad-hoc

BB BIOTECH AG

Ad-hoc

BB Biotech AG publishes its 2023 annual report

14 February 2024

07:00 Corporate

BB BIOTECH AG

Corporate

Investor interest returns – dividend yield remains high for 2024

19 January 2024

07:00 Ad-hoc

BB BIOTECH AG

Ad-hoc

BB Biotech AG publishes financial results for 2023 and changes to the Board of Directors

07:00 Corporate

BB BIOTECH AG

Corporate

BB Biotech AG: End of year biotech equity market rally – M&A and end of rate hike cycle

20 October 2023

07:00 Ad-hoc

BB BIOTECH AG

Ad-hoc

BB Biotech AG publishes its interim report

07:00 Corporate

BB BIOTECH AG

Corporate

BB BIOTECH AG: Biotech equity markets in flux: the impact of rising bond yields and shifting healthcare policies

21 July 2023

07:00 Corporate

BB BIOTECH AG

Corporate

BB BIOTECH AG: Sector rotation and fund outflows weigh on biotech stocks, but positive developments allow fund raising to strengthen industry

07:00 Ad-hoc

BB BIOTECH AG

Ad-hoc

BB Biotech AG publishes its interim report

3 May 2023

07:00 Corporate

BB BIOTECH AG

Corporate

BB BIOTECH AG: Creating blockbuster drugs using algorithms

21 April 2023

07:00 Ad-hoc

BB BIOTECH AG

Ad-hoc

BB Biotech AG publishes its interim report

07:00 Corporate

BB BIOTECH AG

Corporate

BB BIOTECH AG: Lackluster first quarter for biotech stocks

23 March 2023

17:45 Corporate

BB BIOTECH AG

Corporate

Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.85 per share

17 February 2023

07:00 Ad-hoc

BB BIOTECH AG

Ad-hoc

BB Biotech AG publishes its 2022 annual report

20 January 2023

07:00 Ad-hoc

BB BIOTECH AG

Ad-hoc

BB Biotech AG closes the 2022 fiscal year with a loss

07:00 Corporate

BB BIOTECH AG

Corporate

BB BIOTECH AG: Divergent biotech equity markets mirror value over growth theme in 2022 – Proposed dividend of CHF 2.85

8 December 2022

17:00 Corporate

BB BIOTECH AG

Corporate

BB BIOTECH AG: Molecular strike force for the immune system

21 October 2022

07:00 Ad-hoc

BB BIOTECH AG

Ad-hoc

BB Biotech AG publishes its interim report

07:00 Corporate

BB BIOTECH AG

Corporate

BB BIOTECH AG: US drug pricing legislation drives biotech business to adapt for further innovation

30 August 2022

11:00 Corporate

BB BIOTECH AG

Corporate

BB BIOTECH AG: Moderna was just the beginning

22 July 2022

07:00 Ad-hoc

BB BIOTECH AG

Ad-hoc

BB Biotech AG publishes its interim report

07:00 Corporate

BB BIOTECH AG

Corporate

BB BIOTECH AG: First signs of increased M&A activity due to attractive valuations

24 May 2022

07:30 Corporate

BB BIOTECH AG

Corporate

BB BIOTECH AG: Disruptive technologies are changing an entire industry

22 April 2022

07:00 Ad-hoc

BB BIOTECH AG

Ad-hoc

BB Biotech AG publishes its interim report

07:00 Corporate

BB BIOTECH AG

Corporate

BB BIOTECH AG: Increased investment level balanced by established core holdings

12 April 2022

07:00 Corporate

BB BIOTECH AG

Corporate

BB Biotech AG concludes its share buyback program and launches a new buyback program

17 March 2022

18:00 Corporate

BB BIOTECH AG

Corporate

Shareholders at BB Biotech AG’s AGM vote in favor of all proposals, approve the dividend of CHF 3.85 per share and elect two new board members

Upcoming Events

26

Apr 24

BB BIOTECH AG

Publication quarterly financial report (call-date Q1)

26

Jul 24

BB BIOTECH AG

Publication half-yearly financial report

25

Oct 24

BB BIOTECH AG

Publication quarterly financial report (call-date Q3)